ABUS Archived Articles
Arbutus Biopharma: Advancing Innovative Therapies for Chronic Hepatitis B
Published on March 13, 2025
Arbutus Biopharma (ABUS): Advancing a Potential Functional Cure for Chronic Hepatitis B
Published on November 17, 2024
Arbutus Biopharma Corporation (NASDAQ:ABUS): Advancing Towards a Functional Cure for Chronic Hepatitis B
Published on September 24, 2024